On July 31, 2025, Pennsylvania Attorney General Dave Sunday announced criminal charges against a Philadelphia pharmacy accused of orchestrating a multi-million dollar scheme to defraud the Medicaid and Medicare programs through improper reimbursement claims for HIV medications.
According to the investigation, the pharmacy submitted more than $2 million in reimbursement claims for HIV medications it falsely represented as having been purchased from legitimate wholesale distributors, as required by law. In reality, the medications had been sourced from unauthorized suppliers.
Employees told investigators that the HIV medications stocked by the pharmacy were not from approved wholesalers. The Office of Attorney General’s Medicaid Fraud Control Section confirmed these claims through its investigation.
The pharmacy faces three counts of Medicaid fraud, one count of theft by deception, and one count of violating the Controlled Substance, Drug, Device, and Cosmetics Act.
Employees reported that the owner was acquiring high-cost HIV medications from non-authorized sources and placing them on pharmacy shelves for patient use. The bottles were described as “sticky,” suggesting that original labels had been removed or altered.
Under federal and state regulations, prescription medications must pass through a secure supply chain—from manufacturers to a limited number of authorized wholesale distributors—before reaching pharmacies. Investigators estimate that nearly 100,000 tablets of HIV medications dispensed at the pharmacy were not obtained through documented, authorized channels.
“This pharmacy cut corners to maximize profits while putting patients at risk and defrauding taxpayers who fund the Medicaid program,” said Attorney General Sunday. “Our thorough investigation revealed that patients who depended on these life-saving medications were, in reality, receiving diverted or unregulated drugs that the pharmacy obtained from unknown, unapproved sources.”
The investigation was conducted jointly by the Office of Attorney General and the Department of Health and Human Services – Office of Inspector General. Investigators found no evidence that patients experienced physical harm or illness as a result of the medications dispensed. The pharmacy, along with several other businesses owned by the same individual, has since closed.
Compliance Perspective
Issue
The integrity of the pharmaceutical supply chain is critical to ensuring that patients receive medications that are safe, effective, and legally sourced. Medications obtained from unauthorized or unlicensed sources fall outside the protections of federal and state oversight, raising concerns about their safety, authenticity, and effectiveness. Long-term care facilities must take proactive steps to ensure that all medications administered to residents are acquired exclusively through authorized channels that comply with federal and state regulations. Failure to do so not only compromises resident safety but may also expose the facility to legal liability and regulatory sanctions.
Discussion Points
- Review and revise medication procurement and management policies to require that all medications are obtained solely from licensed wholesale distributors and pharmacies authorized under federal and state law. Policies should include procedures for verifying suppliers, documenting purchases, identifying supply chain irregularities, and reporting suspected noncompliance. Facilities may benefit from engaging external reviewers or consultants to help evaluate current procedures and implement safeguards consistent with industry best practices.
- Ensure staff receive regular training on medication safety, including how to recognize signs of potentially diverted or unauthorized drugs and understand the risks associated with compromised medications. Emphasize the importance of following approved procurement protocols and verifying medication sources at every point in the chain—from delivery to administration. Facilities may consider offering supplemental training, such as Med-Net Academy’s Drug Diversion: What Every Nursing Facility Needs to Know course, to help staff identify commonly abused prescription medications, recognize signs of potential drug diversion or substance use disorders, and understand appropriate reporting procedures. Resident and family education should reinforce the facility’s policy of not accepting medications from outside sources.
- Conduct regular audits of medication inventories, purchase records, and supplier documentation to verify sourcing through authorized channels. Facilities may consider partnering with consultants to perform targeted reviews or mock surveys that assess medication-related practices and supply chain integrity. Findings should be incorporated into QAPI initiatives, and audit results should be reviewed by leadership to implement timely corrective actions.
*This news alert has been prepared by Med-Net Concepts, Inc. for informational purposes only and is not intended to provide legal advice.*